Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
Saved in:
| Title: | Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. |
|---|---|
| Authors: | Mathad JS; Department of Medicine and Obstetrics and Gynecology, Center for Global Health, Weill Cornell Medicine, New York, New York, USA., Savic R; University of California-San Francisco, San Francisco, California, USA., Britto P; Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Jayachandran P; University of California-San Francisco, San Francisco, California, USA., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Montepiedra G; Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Norman J; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Zhang N; University of California-San Francisco, San Francisco, California, USA., Townley E; Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA., Chakhtoura N; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA., Bradford S; FHI 360, Durham, North Carolina, USA., Patil S; BJ Medical College-Johns Hopkins CTU, Pune, India., Popson S; Frontier Science and Technology Research Foundation, Inc, Amherst, New York, USA., Chipato T; University of Zimbabwe College of Health Sciences-Clinical Trials Research Centre, Harare, Zimbabwe., Rouzier V; Department of Medicine and Obstetrics and Gynecology, Center for Global Health, Weill Cornell Medicine, New York, New York, USA.; Les Centres GHESKIO Clinical Research Site, Port-au-Prince, Haiti., Langat D; Kenya Medical Research Institute/Walter Reed Project Clinical Research Center, Kericho, Kenya., Chalermchockcharoentkit A; Siriraj Hospital, Mahidol University, Bangkok, Thailand., Kamthunzi P; University of North Carolina Project-Malawi, Lilongwe, Malawi., Gupta A; BJ Medical College-Johns Hopkins CTU, Pune, India.; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Dooley KE; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 May 03; Vol. 74 (9), pp. 1604-1613. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciab665 |